SecBot SecBot
SC 13G/A ·Filed Nov 2, 2026

SNGX

SOLIGENIX, INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed14d 12h ago SEC0002103370-26-000005
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a Schedule 13D, which would signal activist intent. The passive filing indicates no control-related activity, but the stake is material at 9.4%.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$0.3612
T+0 close · Nov 2, 2026 · via day close
Latest settled
−5.37%
T+5 · $0.3418 · next T+20 in 14d
Vs SPY
−5.45%
α at T+5
Latest observation
−5.90%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $0.3612entry
  2. T+1 · 14d ago −1.41%α −1.71% · $0.3561
  3. T+5 · 8d ago −5.37%α −5.45% · $0.3418
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MJL Manager LLC, Michael Liu, and Capuchin Capital Fund LP filed an amended Schedule 13G disclosing a 9.4% passive stake in Soligenix, Inc. as of September 30, 2026, representing 2,053,706 shares. The filing is an amendment to a prior 13G filed in June 2026, indicating the stake was updated but the percentage remained unchanged from the prior filing.

Key Financial Metrics

Stake
9.4%
Investor
MJL Manager LLC

Key Facts

  • MJL Manager LLC, Michael Liu, and Capuchin Capital Fund LP collectively own 2,053,706 shares of Soligenix common stock.
  • The stake represents 9.4% of outstanding shares as of September 30, 2026.
  • The filing is an amendment (SC 13G/A) to a prior 13G filed June 25, 2026.
  • The filing certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.

Financial Impact

Passive stake of 9.4% of an $8M market cap company, valued at approximately $752,000 based on market cap.

ownership

Risk Factors

  • No material financial data or changes disclosed beyond the ownership update.
  • The filing does not indicate any change in the size or nature of the stake from the prior filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002103370-26-000005
Document: 0002103370-26-000005-index.html0002103370-26-000005
Document: 0002103370-26-000005.txt0002103370-26-000005

Track record

7 reports on SNGX

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +69.30% at T+20 after the Apr 3, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $0.3350 Now $0.2900 −13.43% settles Feb 4
  2. Nov 2, 202614d ago SC 13G/A Neutral 2/10 Viewing Entry $0.3612 Now $0.2900 −19.71% settles Jan 29
  3. Jun 26, 202620w ago 8-K Bearish 6/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
  4. Jun 26, 202620w ago 424B5 Bearish 7/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
  5. May 28, 202624w ago 8-K Bearish 5/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
  6. May 28, 202624w ago 424B5 Bearish 6/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
  7. Apr 3, 202632w ago EFFECT Bearish 6/10 Entry $1.14 to $0.3970 Now $0.2900 +74.56% ▲ +65.18% +78.64% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026